The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Design and Discovery of Water-Soluble Benzooxaphosphole-Based Ligands for Hindered Suzuki–Miyaura Coupling Reactions with Low Catalyst Load
作者:Arun D. R. Shada、Hari P. R. Mangunuru、Leila Terrab、Srinivasarao Tenneti、Nageswara Rao Kalikinidi、Santhosh Reddy Naini、Praveen Gajula、Emily B. Crull、Venumadhav Janganati、Raghavendra Kovvuri、Vasudevan Natarajan、Daniel Lee、Jinya Yin、Lalith Samankumara、Rohit Mahar、Xueyi Zhang、Anji Chen、Chathuranga C. Hewa-Rahinduwage、Zhirui Wang、Manasa Mamunooru、Jagruti Rana、Chaitanya S. Wannere、Joseph D. Armstrong、R. Thomas Williamson、Gopal Sirasani、Bo Qu、Chris H. Senanayake
DOI:10.1021/acs.orglett.3c01663
日期:2024.4.12
benzooxaphosphole-based, water-soluble ligands in the application of Suzuki–Miyaura cross-coupling reactions for stericallyhindered substrates in aqueous media. The catalytic activities of the coupling reactions were greatly enhanced by the addition of catalytic amounts of organic phase transfer reagents, such as tetraglyme and tetrabutylammonium bromide. The optimized general protocol can be conducted